A new American Heart Association scientific statement suggests surgery be considered for more people with high-risk pulmonary embolism (PE). The statement, published today in the American Heart Association's flagship peer-reviewed ...
Jan 23, 2023
0
11
Progression-free survival is significantly longer with zanubrutinib than ibrutinib among patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), according to a study published ...
Jan 3, 2023
0
7
For many parents, respiratory syncytial virus—or RSV—which has been causing record numbers of hospitalizations of children during the fall of 2022, may sound like a relatively new and unheard-of threat. But in fact, RSV ...
Dec 16, 2022
0
8
A three-drug combination that sent chronic lymphocytic leukemia (CLL) into deep remission in a broad group of patients in a clinical trial is highly effective in patients with high-risk forms of the disease, a new, phase ...
Dec 10, 2022
0
45
The EU's drug watchdog warned on Friday that antibody treatments for COVID are ineffective against the newest and increasingly dominant strains of the disease.
Dec 9, 2022
0
38
In a new study published in Circulation: Genomics & Precision Medicine, Mayo Clinic researchers designed and developed the first suppression-replacement KCNH2 gene therapy for correcting both long QT syndrome (LQTS) and short ...
Nov 21, 2022
0
4
A new study by Indiana University researchers has found that about 45% of patients who visit the emergency department for physical injuries and ailments also have mental health and substance use problems that are often overlooked. ...
Nov 17, 2022
0
27
According to an accepted manuscript published in ARRS' American Journal of Roentgenology, diagnostic performance of LR-5 for hepatocellular carcinoma (HCC) diagnosis was not significantly different between modified contrast-enhanced ...
Nov 16, 2022
0
1
A large study of COVID-19 disease following vaccination and booster, published in the Journal of the American Medical Association (JAMA), reports surprisingly low incidence, especially in individuals younger than 65 years ...
Oct 6, 2022
0
14
By using artificial intelligence, Houston Methodist researchers are able to predict hospitalization outcomes of geriatric patients with dementia on the first or second day of hospital admission. This early assessment of outcomes ...
Sep 29, 2022
0
12
